Brainstorm Cell Therapeutics Inc. SEC filings BCLI
Brainstorm Cell Therapeutics Inc. has 949 filings in SEC EDGAR's recent list, going back to May 24, 2001. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 21, 2026 | — |
| S-1 | Registration statement | May 21, 2026 | — |
| S-8 | Employee stock plan registration | Jul 3, 2025 | — |
| S-3 | Shelf registration | Jun 25, 2025 | — |
| S-3/A | Form s-3/a | Sep 24, 2024 | — |
| S-3 | Shelf registration | Sep 17, 2024 | — |
| S-3 | Shelf registration | Aug 28, 2024 | — |
| 424B5 | Prospectus supplement | Jun 28, 2024 | — |
| 424B5 | Prospectus supplement | Jun 27, 2024 | — |
| 424B5 | Prospectus supplement | Apr 2, 2024 | — |
| 424B5 | Prospectus supplement | Jul 19, 2023 | — |
| S-8 | Employee stock plan registration | Dec 10, 2021 | — |
| S-3 | Shelf registration | Aug 9, 2021 | — |
| 424B5 | Prospectus supplement | Sep 25, 2020 | — |
| 424B3 | Prospectus | Aug 7, 2020 | — |
| 424B3 | Prospectus | Jun 26, 2020 | — |
| 424B3 | Prospectus | Jun 26, 2020 | — |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 424B5 | Prospectus supplement | Mar 6, 2020 | — |
| 424B1 | Filing | Aug 30, 2019 | — |
| S-3 | Shelf registration | Aug 16, 2019 | — |
| 424B3 | Prospectus | Aug 2, 2019 | — |
| 424B5 | Prospectus supplement | Jun 11, 2019 | — |
| S-8 | Employee stock plan registration | Dec 21, 2018 | — |
| 424B1 | Filing | Sep 28, 2018 | — |
| S-3/A | Filing | Sep 21, 2018 | — |
| S-3 | Shelf registration | Jun 29, 2018 | — |
| S-3 | Shelf registration | Jun 8, 2018 | — |
| 424B3 | Prospectus | Jun 7, 2018 | — |
| POS AM | Filing | Nov 14, 2016 | — |
| S-8 | Employee stock plan registration | Sep 20, 2016 | — |
| 424B3 | Prospectus | Aug 12, 2016 | — |
| 424B3 | Prospectus | May 10, 2016 | — |
| 424B3 | Prospectus | May 10, 2016 | — |
| 424B3 | Prospectus | Nov 17, 2015 | — |
| 424B3 | Prospectus | Aug 13, 2015 | — |
| S-3 | Shelf registration | Jun 4, 2015 | — |
| POS AM | Filing | May 27, 2015 | — |
| 424B3 | Prospectus | May 18, 2015 | — |
| 424B3 | Prospectus | May 18, 2015 | — |
| POS AM | Filing | Apr 27, 2015 | — |
| 424B3 | Prospectus | Mar 26, 2015 | — |
| 424B3 | Prospectus | Mar 26, 2015 | — |
| 424B3 | Prospectus | Mar 26, 2015 | — |
| 424B1 | Filing | Feb 10, 2015 | — |
| 424B1 | Filing | Feb 10, 2015 | — |
| S-3 | Shelf registration | Jan 26, 2015 | — |
| S-3 | Shelf registration | Jan 26, 2015 | — |
| 424B3 | Prospectus | Jan 8, 2015 | — |
| 424B3 | Prospectus | Nov 13, 2014 | — |
| 424B3 | Prospectus | Nov 13, 2014 | — |
| 424B3 | Prospectus | Nov 13, 2014 | — |
| 424B3 | Prospectus | Aug 27, 2014 | — |
| 424B3 | Prospectus | Aug 27, 2014 | — |
| 424B3 | Prospectus | Aug 27, 2014 | — |
| S-8 | Employee stock plan registration | Aug 27, 2014 | — |
| 424B3 | Prospectus | Aug 12, 2014 | — |
| 424B3 | Prospectus | Aug 12, 2014 | — |
| 424B3 | Prospectus | Aug 12, 2014 | — |
| 424B1 | Filing | Jul 24, 2014 | — |
| S-1 | Registration statement | Jul 10, 2014 | — |
| 424B3 | Prospectus | May 13, 2014 | — |
| 424B3 | Prospectus | May 13, 2014 | — |
| 424B3 | Prospectus | Mar 28, 2014 | — |
| 424B3 | Prospectus | Mar 28, 2014 | — |
| 424B3 | Prospectus | Nov 14, 2013 | — |
| 424B3 | Prospectus | Nov 14, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B3 | Prospectus | Aug 16, 2013 | — |
| 424B1 | Filing | Aug 13, 2013 | — |
| FWP | Free writing prospectus | Aug 7, 2013 | — |
| S-1/A | Amended registration statement | Aug 6, 2013 | — |
| S-1/A | Amended registration statement | Jul 9, 2013 | — |
| S-1/A | Amended registration statement | Jun 12, 2013 | — |
| S-1/A | Amended registration statement | May 13, 2013 | — |
| S-1/A | Amended registration statement | Mar 20, 2013 | — |
| S-1 | Registration statement | Feb 8, 2013 | — |
| 424B1 | Filing | Jul 19, 2012 | — |
| S-1/A | Amended registration statement | Jul 10, 2012 | — |
| S-8 | Employee stock plan registration | Jul 5, 2012 | — |
| S-1/A | Amended registration statement | Jun 29, 2012 | — |
| S-1/A | Amended registration statement | May 17, 2012 | — |
| S-1/A | Amended registration statement | Mar 22, 2012 | — |
| S-1 | Registration statement | Feb 3, 2012 | — |
| S-8 | Employee stock plan registration | Jul 11, 2011 | — |
| S-8 | Employee stock plan registration | Aug 11, 2010 | — |
| POS AM | Filing | Aug 11, 2010 | — |
| S-8 | Employee stock plan registration | Feb 15, 2006 | — |
| S-1/A | Amended registration statement | Mar 3, 2003 | — |
| S-1/A | Amended registration statement | Aug 17, 2001 | — |
| S-1/A | Amended registration statement | Jul 25, 2001 | — |
| S-1/A | Amended registration statement | Jun 18, 2001 | — |
| S-1 | Registration statement | May 24, 2001 | — |
Showing 97 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCLI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1137883
- Former names
- BRAINSTORM CELL THERAPEUTICS INC (until Jul 23, 2012); GOLDEN HAND RESOURCES INC (until Nov 22, 2004); WIZBANG TECHNOLOGIES INC (until Aug 8, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.